Dr Jonathon Arnold
D06 - Blackburn Building
The University of Sydney NSW 2006 Australia |
|
Dr Jonathon is an internationally-recognised researcher in the pharmacology of cannabis and the cannabinoids (cannabis-like drugs).
Current national competitive grants
|
2010 |
|
|
Role of ABC transporters in resistance to antipsychotic therapy and cannabinoid antipsychotic drug interactions |
|
| NARSAD Research Support | $70,000 over 2 years |
2010
- Carson, D, Hunt, G, Guastella, A, Barber, L, Cornish, J, Arnold, J, Boucher, A, McGregor, I. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction biology. 2010; :
- van Nieuwenhuijzen, P, Long, L, Hunt, G, Arnold, J, McGregor, I. Residual social, memory and oxytocin-related changes in rats following repeated exposure to gamma-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology. 2010; :
2009
- Gunasekaran, N, Long, L, Dawson, B, Hansen, G, Richardson, D, Li, K, Arnold, J, McGregor, I. Reintoxication: the release of fat-stored Delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology. 2009; 158:1330-1337
- Long, L, Chesworth, R, Huang, X, McGregor, I, Arnold, J, Karl, T. A behavioural comparison of acute and chronic D9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. International Journal of Neuropsychopharmacology. 2009; 0:1-16
- Boucher, A, Vivier, L, Metna-Laurent, M, Brayda-Bruno, L, Mons, N, Arnold, J, Micheau, J. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. Behavioural Pharmacology. 2009; 20:45-55
2008
- Jiwane, A, Holland, A, Soundappan, S, Arnold, J. Letters to the editor. Journal of paediatrics and child health. 2008; 44:747-749
- Holland, M, Allen, J, Arnold, J. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European journal of pharmacology. 2008; 591:128-31
- Quinn, H, Matsumoto, I, Callaghan, P, Long, L, Arnold, J, Gunasekaran, N, Thompson, M, Dawson, B, Mallet, P, Kashem, M, Matsuda-Matsumoto, H, Iwazaki, T, McGregor, I. Adolescent Rats Find Repeated Delta(9)-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008; 33:1113-26
2007
- Boucher, A, Hunt, G, Karl, T, Micheau, J, McGregor, I, Arnold, J. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience. 2007; 149:861-70
- McGregor, I, Arnold, J. Cannabis reward: biased towards the fairer sex?. British journal of pharmacology. 2007; 152:562-4
- Holland, M, Lau, D, Allen, J, Arnold, J. The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. British journal of pharmacology. 2007; 152:815-24
- Boucher, A, Arnold, J, Duffy, L, Schofield, P, Micheau, J, Karl, T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology. 2007; 192:325-336
2006
- Karl, T, Duffy, L, Boucher, A, Arnold, J, Schofield, P. Genetic animal models for neuregulin 1 - valuable tools for schizophrenia research?. Australian and New Zealand Journal of Psychiatry. 2006; 40:A115-A115
- Holland, M, Panetta, J, Hoskins, J, Bebawy, M, Roufogalis, B, Allen, J, Arnold, J. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical pharmacology. 2006; 71:1146-54
2005
- Morley, K, Arnold, J, McGregor, I. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Progress in neuro-psychopharmacology & biological psychiatry. 2005; 29:648-57
- Arnold, J. The role of endocannabinoid transmission in cocaine addiction. Pharmacology, biochemistry, and behavior. 2005; 81:396-406
2001
- Arnold, J, Hunt, G, McGregor, I. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sciences. 2001; 70:97-108
